Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 71 (HNRNPA1P71) is designated as a human processed pseudogene on chromosome 12. Pseudogenes are DNA sequences that resemble normal genes but typically lack the ability to encode functional proteins due to accumulated mutations or lack of necessary regulatory elements. Unlike its parental gene HNRNPA1, which encodes a protein involved in RNA processing, HNRNPA1P71 does not produce a protein product or serve as a typical therapeutic target. Some pseudogenes have regulatory roles in gene expression and have been implicated in diseases such as cancer by acting as competitive endogenous RNAs or participating in network regulation, but specific functional or disease associations for HNRNPA1P71 are not documented in current curated resources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 71 (HNRNPA1P71).